Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Annals of Internal Medicine|February 2, 2026
In patients with CAD, clopidogrel vs. aspirin monotherapy reduces MACCE without increasing major bleedingMichelle D Kelsey, Annals of Internal Medicine|September 14, 2020
In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 yearMichelle D Kelsey, L Kristin NewbyCurrent Cardiology Reports|October 9, 2023
Should We "RESPECT EPA" More Now? EPA and DHA for Cardiovascular Risk ReductionMichelle D Kelsey, Neha J PagidipatiAnnals of Internal Medicine|March 3, 2025
In patients with acute MI, spironolactone did not reduce cardiac events at 3 yMichelle D Kelsey, L Kristin Newby, Annals of Internal Medicine|December 14, 2020
In patients at high CV risk receiving simvastatin, the Myopathy Risk Score predicted statin-related myopathyMichelle D Kelsey, L Kristin NewbyAnnals of Internal Medicine|October 31, 2022
In ASCVD, moderate-intensity statin + ezetimibe was noninferior to high-intensity statin alone at 3 yMichelle D Kelsey, L Kristin NewbyAnnals of Internal Medicine|August 1, 2022
Recommendations for use of ezetimibe and/or PCSK9 inhibitors in patients with elevated LDL-CMichelle D Kelsey, L Kristin NewbyAnnals of Internal Medicine|February 28, 2022
In CV disease, GLP-1 RAs and SGLT2 inhibitors reduce CV mortalityMichelle D Kelsey, L Kristin NewbyAnnals of Internal Medicine|July 3, 2023
In statin-intolerant adults with, or at risk for, CV disease, bempedoic acid reduced MACE at a median 41 moMichelle D Kelsey, L Kristin NewbyAnnals of Internal Medicine|May 3, 2021
LOW-HARM score predicted mortality in patients hospitalized with COVID-19 in MexicoMichelle D Kelsey, Christopher B GrangerPageof 4